Home » Newsletters » BioWorld

BioWorld

Feb. 10, 1993

View Archived Issues

HOLLINGS RENTON MOVES TO ONYX

CYTOGEN GAINS CANCER MAB LICENSE

EPIGEN FILES BROAD PATENT ON CARCINOMA ANTIGEN

IMCLONE STARTS CANCER VACCINE TRIALS

REGENERON'S SECOND CNTF PATENT ALLOWED

HOFFMAN-LAROCHE FACES AIDS ACTIVISTS

PROCYTE COMPLETES OFFERING

MACROCHEM NETS $6.3 MILLION IN PRIVATE PLACEMENT

EMISPHERE OFFERING TO BEGIN TRADING

CEPHALON FILES SECONDARY

CELL GENESYS GETS $10M TO DEVELOP MAbs

BIOSYS TO BUY PHEROMONE FIRM

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 23, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...